11/1/2019
Overcoming 10 Barriers to Participating in Clinical Trials
We put together a list of some of the most common perceived barriers to participating in clinical trials, and how to overcome them.
Continue ReadingResearch News
10/24/2019
Cour Pharmaceuticals Announces Deal with Takeda for Celiac Treatment
Cour Pharmaceuticals has announced a $420 million licensing deal with Takeda Pharmaceuticals following a favorable outcome of their phase 2 trial for celiac disease. The company released data from a…
Continue Reading10/3/2019
Preliminary Study Suggests That Risk of Gluten Transfer in Common-Cooking Activities May Be Lower Than Previously Thought
Parents using multiple kitchen appliances and utensils to prevent their child with celiac disease from being exposed to gluten may be able to eliminate some cumbersome steps. A new, preliminary…
Continue Reading10/3/2019
Senate Approves NIH Language for Celiac Disease
CEO Marilyn G. Geller’s testimony before the House Appropriations Subcommittee has helped secure report language in the House’s version of the 2020 Labor-HHS-Education bill demanding that the National Institute of…
Continue Reading9/23/2019
Psychological Symptoms in Childhood Celiac Disease
Researchers found that children with celiac disease have a 1.2-1.8 higher risk of psychological conditions such as depression, mood disorders, behavioral problems, ADHD, eating disorders, autism, and other intellectual disabilities.
Continue ReadingRecent Posts
- The 2024 Nobel Prize in Chemistry goes to a leading celiac disease researcher
- Biomarkers May Help Predict Celiac Disease in Patients with Type 1 Diabetes
- New Wheat Discovery Could Reduce the Impact of Celiac Disease
- Adriana Carrieri's Rising Villus Award for Celiac College Research
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Research News
- Research Press
- Trending Topics
Marilyn's Message
9/26/2024
Read more2024 International Celiac Disease Symposium Recap
Last month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...